About Vitality Reset Medical

We're not just another telehealth company.

Vitality Reset Medical was created because we were tired of watching people struggle to get real care.

Too many patients fall through the cracks — waiting months for appointments, dealing with providers who don't listen, or being forced to choose between their mental health and their physical health.

We believe you shouldn't have to choose.

That's why we built a clinic that treats both your mind and your body with the same level of care. From medical weight loss with GLP-1s — which have been shown to reduce body weight by an average of 14.9% — to low-dose ketamine therapy, which is proven to rapidly improve depression and anxiety symptoms within hours, to convenient treatment for ED and hair loss — we make it simple to finally get the help you deserve.

Every provider at Vitality Reset Medical is licensed, experienced, and genuinely cares about results. No corporate nonsense. No long waiting lists. Just real medicine, real support, and real results — all from the comfort of your home.

This isn't just healthcare.
This is a reset.

Clinician-led

Every program is designed and supervised by board-certified physicians and psychiatric clinicians.

Whole-person

We connect physical and mental health, instead of treating them in separate silos.

Transparent

Flat monthly pricing. No insurance required. Cancel anytime, no fees.

Private

HIPAA-compliant infrastructure and discreet, unmarked shipping by default.

Verify our credentials

Every clinician at Vitality Reset Medical is Florida-licensed and board-certified. Read more about our medical team, how we review medical content, and our editorial policy.

Ready to feel like yourself again?

Start a confidential visit in minutes. Pay only if prescribed.

Scientific References

Peer-reviewed studies (2021 and newer) referenced on this page.

  1. Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025.
  2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216.
  3. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
  4. Bahji A, et al. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis. 2024.
  5. Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine. 2025.
  6. Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment-resistant depression. 2024.
  7. Johnson et al. Effectiveness of Combined Oral Minoxidil and Finasteride in Men with Androgenetic Alopecia. 2025.
  8. Abeck D, et al. Patient-reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia. J Cosmet Dermatol. 2024.
  9. Piraccini BM, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. J Cosmet Dermatol. 2022.
  10. Pyrgidis N, et al. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. JAMA Network Open. 2021;4(2):e2036337.
  11. Huang Y, et al. Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses. BMJ Open. 2021;11(8):e047396.
  12. Associations between phosphodiesterase type 5 inhibitors and vascular function: a systematic review and meta-analysis of randomized controlled trials. Systematic Reviews. 2025.
Call (786) 868-0920